CTI BIOPHARMA CORP Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2013 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Cti Biopharma Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2013 to Q1 2023.
  • Cti Biopharma Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 132M shares, a 31.8% increase year-over-year.
  • Cti Biopharma Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 115M shares, a 27.3% increase from 2021.
  • Cti Biopharma Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 90.1M shares, a 26.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 132M +31.7M +31.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 115M +24.6M +27.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 122M +27.8M +29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 109M +16.2M +17.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 99.8M +23.5M +30.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 90.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 93.8M +20.1M +27.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 92.3M +18.7M +25.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 76.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 73.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 73.7M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q2 2018 57.9M +26M +81.6% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-03
Q2 2017 31.9M +3.94M +14.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 28M +229K +0.82% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-03
Q2 2016 28M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 27.8M -146M -84% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2015 176M +28.9M +19.7% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q1 2015 174M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 147M +36.1M +32.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q3 2013 111M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.